OHB SERecord backlog, double-digit growth, and confirmed guidance indicate strong financial performance.

OHB SE reported total operating performance of EUR628 million in H1 2026, up from EUR470 million in H1 2024, representing double-digit growth. Adjusted EBITDA rose over 30% to EUR60 million with a margin of 9.6%, while the company confirmed its full-year 2026 guidance of about EUR1.4 billion in total operating performance and an adjusted EBITDA margin of 10.5% to 11%. The backlog reached a record high, supported by a pipeline of EUR20 billion in new projects, and net leverage improved to minus 1.1 following a EUR480 million capital increase. The Space Systems segment contributed EUR472 million in total operating performance, and the Access to Space segment grew more than 30% year-on-year, though its margins were softer due to ramp-up costs. The Digital segment backlog increased 70% year-on-year, and the workforce grew 50% to nearly 4,100 employees.
OHB SERecord backlog, double-digit growth, and confirmed guidance indicate strong financial performance.
Novartis AG